3',4'-Dihydro-2'H-spiro[imidazolidine-4,1'-naphthalene]-2,5-dione

Catalog No.: 
ACROJU361
CAS No.: 
57998-96-6
Molecular Formula: 
C12H12N2O2
Molecular Weight: 
216.24
3',4'-Dihydro-2'H-spiro[imidazolidine-4,1'-naphthalene]-2,5-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$181.00InquiryInquiry
1g95%$421.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3',4'-Dihydro-2'H-spiro[imidazolidine-4,1'-naphthalene]-2,5-dione
IUPAC Name3',4'-dihydro-2'H-spiro[imidazolidine-4,1'-naphthalene]-2,5-dione
MDL No.MFCD00666132
Molecular FormulaC12H12N2O2
Molecular Weight216.24
SMILESO=C1NC2(CCCC3=C2C=CC=C3)C(N1)=O
InChI KeyOZYWLMZRNIFQPM-UHFFFAOYSA-N
Synonym3,4-dihydro-2H-spiro[imidazolidine-4,1-naphthalene]-2,5-dione;-Dihydro-2h,2’h,5h-spiro[imidazolidine-4,1’-naphthalene]-2,5-dione;SPIRO(2,5-DIOXO-IMIDAZOLIDINE-4,1'(2'H)-3',4'-DIHYDRO-NAPHTHALENE);SPIRO(2,5-DIOXO-IMIDAZOLIDINE-4,1'(2'H)-3',4'-DIHYDRO-NAPHTHALENE)
CAS No.57998-96-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACROJU361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACROJU361 route product structure diagram
    ACROJU36157998-96-6
Inquiry

2. ACROJU361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACROJU361 route product structure diagram
    ACROJU36157998-96-6
Inquiry

3. ACROJU361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACROJU361 route product structure diagram
    ACROJU36157998-96-6
Inquiry

Comments (0)